187 related articles for article (PubMed ID: 6393318)
1. Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide.
Amland PF; Jorde R; Kildebo S; Burhol PG; Giercksky KE
Scand J Gastroenterol; 1984 Sep; 19(6):857-61. PubMed ID: 6393318
[TBL] [Abstract][Full Text] [Related]
2. Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.
Amland PF; Jorde R; Giercksky KE; Burhol PG
Int J Obes; 1984; 8(2):117-22. PubMed ID: 6373640
[TBL] [Abstract][Full Text] [Related]
3. Lack of negative feed-back regulation of insulin on the responses of gastric inhibitory polypeptide, insulin, glucagon and pancreatic polypeptide to a meal in insulin treated diabetics.
Krarup T; Madsbad S; Tronier B
Diabete Metab; 1984 Sep; 10(3):171-4. PubMed ID: 6386555
[TBL] [Abstract][Full Text] [Related]
4. Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass.
Sirinek KR; O'Dorisio TM; Hill D; McFee AS
Surgery; 1986 Oct; 100(4):781-7. PubMed ID: 3532392
[TBL] [Abstract][Full Text] [Related]
5. [Behavior of plasma insulin and GIP in obese patients subjected to biliopancreatic bypass].
Gianetta E; Bloom SR; Sarson DL; Civalleri D; Bonalumi U; Friedman D; Adami GF; Pitton L; Brignole E; Traverso E; Scopinaro N
Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1922-8. PubMed ID: 7006641
[TBL] [Abstract][Full Text] [Related]
6. Gastric acid secretion and gastrin and gastric inhibitory polypeptide release in cirrhotic patients.
Sato T; Imamura M; Sasaki I; Ohneda A
Am J Gastroenterol; 1985 Mar; 80(3):163-9. PubMed ID: 3883751
[TBL] [Abstract][Full Text] [Related]
7. Effect of single dose of omeprazole on the gastrointestinal peptide response to food.
Allen JM; Adrian TE; Webster J; Howe A; Bloom SR
Hepatogastroenterology; 1984 Feb; 31(1):44-6. PubMed ID: 6365714
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.
Meryn S; Stein D; Straus EW
Int J Obes; 1986; 10(1):37-42. PubMed ID: 3710688
[TBL] [Abstract][Full Text] [Related]
9. Fasting- and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity.
Meryn S; Stein D; Straus EW
Metabolism; 1986 Sep; 35(9):798-802. PubMed ID: 3528741
[TBL] [Abstract][Full Text] [Related]
10. The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man.
Jorde R; Waldum HL; Burhol PG; Lygren I; Schulz TB; Florholmen J; Jenssen TG
Scand J Gastroenterol; 1981; 16(1):113-9. PubMed ID: 6112787
[TBL] [Abstract][Full Text] [Related]
11. Effects of physical training on insulin, connecting peptide (C-peptide), gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) levels in obese subjects.
Krotkiewski M; Björntorp P; Holm G; Marks V; Morgan L; Smith U; Feurle GE
Int J Obes; 1984; 8(3):193-9. PubMed ID: 6378815
[TBL] [Abstract][Full Text] [Related]
12. Similar plasma GIP responses in obese and lean subjects after an oral test meal and after intraduodenal stimulation with fat and glucose.
Amland PF; Jorde R; Burhol PG; Giercksky KE
Int J Obes; 1984; 8(6):649-53. PubMed ID: 6398318
[TBL] [Abstract][Full Text] [Related]
13. Release of gastric inhibitory peptide following a peptone meal in the dog.
Wolfe MM; McGuigan JE
Gastroenterology; 1982 Oct; 83(4):864-72. PubMed ID: 7049826
[TBL] [Abstract][Full Text] [Related]
14. [Behavior of plasma pancreatic polypeptides and motilin in obese patients subjected to biliopancreatic bypass].
Civalleri D; Bloom SR; Sarson DL; Gianetta E; Bonalumi U; Friedman D; Pitton L; Brignole E; Binda PL; Degrandi R; Scopinaro N
Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1929-35. PubMed ID: 7459103
[TBL] [Abstract][Full Text] [Related]
15. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.
Schattenmann G; Ebert R; Siewert R; Creutzfeldt W
Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074
[TBL] [Abstract][Full Text] [Related]
16. Fasting and postprandial plasma pancreatic polypeptide (PP) levels in obesity.
Jorde R; Burhol PG
Int J Obes; 1984; 8(5):393-7. PubMed ID: 6394520
[TBL] [Abstract][Full Text] [Related]
17. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
18. Correlations between the postprandial secretions of gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) in man.
Jorde R; Burhol PG
Mater Med Pol; 1987; 19(4):222-4. PubMed ID: 3454828
[No Abstract] [Full Text] [Related]
19. Fasting and postprandial serum gastrin levels in obese and slim subjects, and the effects of surgical treatment for obesity on serum gastrin levels.
Amland PF; Jorde R; Giercksky KE; Kildebo S; Burhol PG
Acta Chir Scand; 1984; 150(3):223-8. PubMed ID: 6464625
[TBL] [Abstract][Full Text] [Related]
20. Release of gastric inhibitory polypeptide in totally pancreatectomized patients.
Miyata M; Izukura M; Hamaji M; Nakao K; Kawashima Y
J Clin Endocrinol Metab; 1985 Jun; 60(6):1261-4. PubMed ID: 3889032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
